Association between apolipoprotein B XbaI polymorphisms and coronary heart disease: A meta-analysis.

Ya Yun Feng, Lu Yang Chen, Yang Liu, Meng Luo, Tian Tian Yang, Yu Hao Hu, Jing Chang, Min Mao
Author Information
  1. Ya Yun Feng: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  2. Lu Yang Chen: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  3. Yang Liu: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  4. Meng Luo: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  5. Tian Tian Yang: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  6. Yu Hao Hu: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  7. Jing Chang: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 1584105002@qq.com. ORCID
  8. Min Mao: Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Abstract

BACKGROUND: To evaluate the association between apolipoprotein B gene polymorphism and coronary heart disease in some populations at home and abroad by means of meta-analysis.
METHODS: Using the strict exclusion criteria for primary screening of the literature and applying the Hardy-Weinberg equilibrium to test the genetic balance of the selected literature. The corresponding models were selected according to the results of the heterogeneity test. The Begg's test and Egger's test were used to evaluate publication bias, and meta-analysis was performed using Stata 12.0.
RESULTS: The study included twelve articles. In the literature, a total of 1596 patients with coronary heart disease and 1431 controls.Meta-analysis results showed no statistical value in the following three genetic models: allelic comparison (a vs A,P = 0.811,OR = 0.95, 95%CI = 0.62-1.46), recessive genetic models (aa vs Aa/AA, P = 0.86,OR = 0.94, 95%CI = 0.45-1.96), or dominant genetic models (aa/Aa vs AA, P = 0.73,OR = 0.92, 95%CI = 0.58-1.47). Subgroup analysis based on ethnicity showed allelic comparison (a vs A,P = 0.464,OR = 1.32, 95%CI = 0.63-2.78), recessive genetic models (aa vs Aa/AA, P = 0.422,OR = 1.52, 95%CI = 0.55-4.21), and dominant genetic models (aa/Aa vs AA, P = 0.551,OR = 1.26, 95%CI = 0.58-2.73) in Asians, allelic comparison (a vs A,P = 0.410,OR = 0.79, 95%CI = 0.45-1.39), recessive genetic models (aa vs Aa/AA, P = 0.041,OR = 0.75,95%CI = 0.57-0.99),dominant genetic models (aa/Aa vs AA, P = 0.385,OR = 0.75, 95%CI = 0.40-1.43) in Caucasian; CONCLUSION: The ApoB(apolipoprotein B) XbaI locus is not a risk factor when it comes to the development of coronary heart disease in the domestic and international populations included in this paper. In Caucasians, people carrying the aa genotype may be less susceptible to CHD (coronary heart disease). The results of recessive genetic models have to take the effect of heterogeneity and sample sizes into account. Further research may require a larger and more rigorous research design.

Keywords

References

  1. JAMA. 2015 Mar 10;313(10):1029-36 [PMID: 25756439]
  2. Clin Chem. 1995 Mar;41(3):424-9 [PMID: 7533671]
  3. J Clin Lab Anal. 2001;15(1):19-24 [PMID: 11170229]
  4. Gene. 2016 Sep 30;590(2):263-9 [PMID: 27236033]
  5. Clin Chim Acta. 2009 May;403(1-2):261 [PMID: 19408349]
  6. Eur Heart J. 2014 Nov 7;35(42):2950-9 [PMID: 25139896]
  7. J Geriatr Cardiol. 2012 Mar;9(1):33-7 [PMID: 22783321]
  8. Ann Hum Biol. 2005 Sep-Oct;32(5):620-9 [PMID: 16316917]
  9. Clin Chim Acta. 2000 Oct;300(1-2):139-49 [PMID: 10958870]
  10. Circulation. 2018 Mar 20;137(12):e67-e492 [PMID: 29386200]
  11. PLoS One. 2015 Mar 20;10(3):e0121147 [PMID: 25793386]
  12. Mol Cells. 1997 Aug 31;7(4):521-5 [PMID: 9339897]
  13. Eur J Epidemiol. 2010 Sep;25(9):603-5 [PMID: 20652370]
  14. Circulation. 2008 Jan 29;117(4):e25-146 [PMID: 18086926]
  15. Hum Biol. 1998 Feb;70(1):47-57 [PMID: 9489234]
  16. Interact Cardiovasc Thorac Surg. 2018 Sep 1;27(3):317-321 [PMID: 29868857]
  17. Arch Gen Psychiatry. 2006 May;63(5):530-8 [PMID: 16651510]

MeSH Term

Apolipoprotein B-100
Coronary Disease
Gene Frequency
Genetic Predisposition to Disease
Heart Disease Risk Factors
Humans
Polymorphism, Genetic
Risk Assessment

Chemicals

APOB protein, human
Apolipoprotein B-100

Word Cloud

Created with Highcharts 10.0.0geneticvsP = 095%CI = 0modelsheartOR = 0coronarydiseaseBtestrecessiveaaapolipoproteinmeta-analysisliteratureresultsalleliccomparisonAa/AAdominantaa/AaAAOR = 1evaluatepopulationsselectedheterogeneityincludedMeta-analysisshowed45-17375XbaImayresearchBACKGROUND:associationgenepolymorphismhomeabroadmeansMETHODS:UsingstrictexclusioncriteriaprimaryscreeningapplyingHardy-WeinbergequilibriumbalancecorrespondingaccordingBegg'sEgger'susedpublicationbiasperformedusingStata120RESULTS:studytwelvearticlestotal1596patients1431controlsstatisticalvaluefollowingthreemodels:8119562-1468694969258-147Subgroupanalysisbasedethnicity4643263-2784225255-4215512658-2Asians410793904157-09938540-143CaucasianCONCLUSION:ApoBlocusriskfactorcomesdevelopmentdomesticinternationalpaperCaucasianspeoplecarryinggenotypelesssusceptibleCHDtakeeffectsamplesizesaccountrequirelargerrigorousdesignAssociationpolymorphismsdisease:ApolipoproteinCoronaryPolymorphism

Similar Articles

Cited By